International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
IC-AIRCM-T3-2026
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 3
May-June 2026
Indexing Partners
Hypoplastic Left Heart Syndrome (HLHS)
| Author(s) | Ms. Srushti Sujan Surve |
|---|---|
| Country | India |
| Abstract | Hypoplastic Left Heart Syndrome (HLHS) is a rare but critical congenital cardiac anomaly characterized by severe underdevelopment of the left ventricle, mitral valve, aortic valve, and ascending aorta, rendering the left heart incapable of supporting systemic circulation. It accounts for 2–3% of congenital heart diseases yet remains one of the most lethal if untreated. Advances in prenatal echocardiography have enabled early diagnosis, while postnatal confirmation is achieved through echocardiography, chest X-ray, ECG, and pulse oximetry. Clinical manifestations typically appear within the first 24–48 hours of life, including cyanosis, respiratory distress, poor perfusion, and shock. The mainstay of management involves staged surgical palliation—Norwood procedure, Bidirectional Glenn, and Fontan completion—or a hybrid approach, with heart transplantation as an alternative. Perfusion strategies during these procedures are focused on maintaining systemic oxygen delivery, preventing pulmonary overcirculation, and ensuring cerebral and myocardial protection. With specialized multidisciplinary care, 10–15 year survival rates now reach 60–70%, although long-term complications such as arrhythmias, right ventricular dysfunction, and protein-losing enteropathy necessitate lifelong follow-up. HLHS continues to be one of the most challenging congenital heart diseases, requiring innovation in surgical, perfusion, and postoperative management to improve outcomes. |
| Keywords | Congenital Heart Disease Staged Surgical Palliation Norwood Procedure Glenn Shunt Fontan Completion Hybrid Procedure Perfusion Management Pediatric Cardiac Surgery Prognosis and Outcomes |
| Field | Biology > Medical / Physiology |
| Published In | Volume 7, Issue 4, July-August 2025 |
| Published On | 2025-08-31 |
| DOI | https://doi.org/10.36948/ijfmr.2025.v07i04.55001 |
Share this

E-ISSN 2582-2160
CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
Powered by Sky Research Publication and Journals